Asunto(s)
Dieta con Restricción de Grasas , Crecimiento , Hipercolesterolemia/dietoterapia , Adolescente , Niño , Preescolar , Humanos , LactanteRESUMEN
OBJECTIVE: To determine the reversibility of the loss of brain parenchyma and ventricular enlargement in patients with anorexia nervosa after refeeding. STUDY DESIGN: Quantitative magnetic resonance imaging was performed on three groups of subjects: (1) 12 female adolescents hospitalized with anorexia nervosa, (2) the same 12 patients after nutritional rehabilitation, a mean of 11.1 months later, and (3) 12 healthy age-matched control subjects. Sixty-four contiguous coronal magnetic resonance images, 3.1 mm thick, were obtained. With a computerized morphometry system, lateral and third ventricular volumes were measured by a single observer unaware of the status of the patient. RESULTS: On admission, patients were malnourished and had lost an average of 11.7 kg (body mass index, 14.3 +/- 2.0 kg/m2). After refeeding, they gained an average of 9.7 kg (body mass index, 17.9 +/- 1.5 kg/m2). Total ventricular volume decreased from 17.1 +/- 5.5 cm3 on admission to 12.4 +/- 3.0 cm3 after refeeding (p < 0.01) and returned to the normal range. The degree of enlargement of the third ventricle was greater than that of the lateral ventricles. There was a significant inverse relationship between body mass index and total ventricular volume (r = -0.63; p < 0.05). CONCLUSION: In patients with anorexia nervosa, cerebral ventricular enlargement correlates with the degree of malnutrition and is reversible with weight gain during long-term follow-up.
Asunto(s)
Anorexia Nerviosa/tratamiento farmacológico , Ventrículos Cerebrales/anatomía & histología , Imagen por Resonancia Magnética , Adolescente , Adulto , Anorexia Nerviosa/complicaciones , Anorexia Nerviosa/patología , Índice de Masa Corporal , Peso Corporal , Ventrículos Cerebrales/patología , Niño , Quimioterapia Combinada , Femenino , Hospitalización , Humanos , Trastornos Nutricionales/complicaciones , Penicilamina/uso terapéutico , Sulfatos/uso terapéutico , Trientina/uso terapéutico , Compuestos de Zinc/uso terapéutico , Sulfato de ZincRESUMEN
Women in whom anorexia nervosa develops during adolescence have failure of linear growth associated with low levels of insulin-like growth factor I (IGF-1). To investigate the pathophysiology of growth retardation in adolescents with anorexia nervosa, we measured basal growth hormone (GH), growth hormone-binding protein (GHBP), IGF-1, and insulin-like growth factor binding protein-3 (IGFBP-3) in three groups of patients: (1) 28 recently hospitalized female adolescents with anorexia nervosa, (2) 23 of the same patients after partial weight restoration, and (3) 28 healthy control subjects matched for age, sex, and pubertal stage. Fasting GH levels in group 1 did not differ significantly from those in group 3. In contrast, serum GHBP (p < 0.001), IGF-1 (p < 0.001), and IGFBP-3 (p < 0.01) were significantly lower in group 1 than in group 3. Serum GHBP and IGFBP-3 levels were positively correlated with body mass index. Serum GHBP levels were low in patients in all five pubertal stages and even in those shown to have adequate GH secretion. In group 2 (after refeeding) the serum IGF-1 concentration increased significantly and GHBP and IGFBP-3 returned to normal. We conclude that patients with anorexia nervosa have diminished GH action resulting in decreased secretion of IGF-1. The positive correlation with body mass index and the reversibility with refeeding suggest that these changes are secondary to malnutrition. Altered GH function that occurs during the years of active growth can explain the growth retardation seen in anorexia nervosa.
Asunto(s)
Anorexia Nerviosa/fisiopatología , Hormona del Crecimiento/metabolismo , Somatomedinas/análisis , Adolescente , Adulto , Anorexia Nerviosa/tratamiento farmacológico , Anorexia Nerviosa/metabolismo , Metabolismo Basal , Índice de Masa Corporal , Proteínas Portadoras/sangre , Estudios de Casos y Controles , Niño , Femenino , Hormona del Crecimiento/sangre , Inhibidores de Crecimiento/sangre , Humanos , Proteínas de Unión a Factor de Crecimiento Similar a la Insulina , Factor I del Crecimiento Similar a la Insulina/análisisRESUMEN
Prevention of atherosclerosis, a major cause of illness and death in our society, is a pediatric responsibility in 1988 and beyond. Significant cardiovascular risk factors are identifiable and alterable in children and adolescents, and are associated with arterial lesions. Cost-effective atherosclerosis prevention can be achieved by identification and treatment of high-risk children and adolescents. The pediatrician should record the family history of all patients at 2 years of age, with periodic updates. The serum cholesterol concentration can then be measured in the office if there is a commitment to quality control; otherwise, a monitored commercial laboratory must be used. It is not unreasonable to measure serum cholesterol concentrations once in all school-age patients. The majority of high-risk patients will respond to nutritional intervention and will not require pharmacotherapy. Until the efficacy and safety of the therapeutic diet are proved beyond doubt, its use should be limited to high-risk patients under pediatric supervision. Studies documenting the growth and development of children receiving dietary therapy must be a major priority of pediatric nutrition. Until that is accomplished, although some pediatricians may prefer to wait, most will use the extensive scientific evidence at hand and their clinical judgment to identify and treat their high-risk patients.
Asunto(s)
Arteriosclerosis/prevención & control , Pediatría , Adolescente , Niño , Humanos , Hipercolesterolemia/diagnóstico , Hipercolesterolemia/terapia , Rol del MédicoRESUMEN
Two populations of immigrants to London and to the West Indies from the Indian subcontinent have higher than expected morbidity and mortality from atherosclerosis but do not show the commonly accepted major risk factors. This study investigated the hypothesis that ghee, a clarified butter product prized in Indian cooking, contains cholesterol oxides and could therefore be an important source of dietary exposure to cholesterol oxides and an explanation for the high atherosclerosis risk. Substantial amounts of cholesterol oxides were found in ghee (12.3% of sterols), but not in fresh butter, by thin-layer and high-performance-liquid chromatography. Dietary exposure to cholesterol oxides from ghee may offer a logical explanation for the high frequency of atherosclerotic complications in these Indian populations.
Asunto(s)
Arteriosclerosis/etiología , Mantequilla/análisis , Colesterol/análogos & derivados , Colesterol/análisis , Grasas de la Dieta/efectos adversos , Mantequilla/efectos adversos , Colesterol/efectos adversos , Colesterol/metabolismo , Cromatografía Líquida de Alta Presión , Dieta Aterogénica , Emigración e Inmigración , Humanos , India/etnología , Londres , Óxidos/análisis , Riesgo , Trinidad y TobagoRESUMEN
Two populations of immigrants to London and to the West Indies from the Indian subcontinent have greater than expected morbidity and mortality from atherosclerosis but do not show the commonly accepted major risk factors. This study investigated the hypothesis that ghee, a clarified butter product prized in Indian cooking, contains cholesterol oxides and could therefore be an important source of dietary exposure to cholesterol oxides and an explanation for the high atherosclerosis risk. Substantial amounts of cholesterol oxides were found in ghee (12.3 percent of sterols), but not in fresh butter, by thin-layer and high-performance-liquid chromatography. Dietary exposure to cholesterol oxides from ghee may offer a logical explanation for the high frequency of atherosclerotic complications in these Indian population.(AU)